Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001567619-20-018010

10% owner bought 550,000 shares at $15.00 ($8,250,000)

  • 10% owner acquired 2,997,030 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Vivo Capital VIII, LLC 10% owner 2020-10-20 Conversion +1,885,611 1,885,611 I
Vivo Capital VIII, LLC 10% owner 2020-10-20 Conversion +523,726 2,409,337 I
Vivo Capital VIII, LLC 10% owner 2020-10-20 Conversion +224,054 2,633,391 I
Vivo Capital VIII, LLC 10% owner 2020-10-20 Conversion +260,380 260,380 I
Vivo Capital VIII, LLC 10% owner 2020-10-20 Conversion +72,320 332,700 I
Vivo Capital VIII, LLC 10% owner 2020-10-20 Conversion +30,939 363,639 I
Vivo Capital VIII, LLC 10% owner 2020-10-20 Purchase +483,267 $15.00 $7,249,005 3,116,658 I
Vivo Capital VIII, LLC 10% owner 2020-10-20 Purchase +66,733 $15.00 $1,000,995 430,372 I
Derivatives
Vivo Capital VIII, LLC 10% owner 2020-10-20 Conversion · Series A Preferred Stock −1,885,611 0 I
Vivo Capital VIII, LLC 10% owner 2020-10-20 Conversion · Series A Preferred Stock −260,380 0 I
Vivo Capital VIII, LLC 10% owner 2020-10-20 Conversion · Series B-1 Preferred Stock −523,726 0 I
Vivo Capital VIII, LLC 10% owner 2020-10-20 Conversion · Series B-1 Preferred Stock −72,320 0 I
Vivo Capital VIII, LLC 10% owner 2020-10-20 Conversion · Series B-2 Preferred Stock −224,054 0 I
Vivo Capital VIII, LLC 10% owner 2020-10-20 Conversion · Series B-2 Preferred Stock −30,939 0 I
Open-market purchases · 550,000 sh · avg $15.00 · $8,250,000
Loading xslF345X03/doc1.xml…